Showing results (801-810 of 1,562) with videos related to
Sort By:
Pageof 157
Journal of Applied Toxicology : JAT|February 25, 2023
Use of the benchmark-dose (BMD) approach to derive occupational exposure limits (OELs) for genotoxic carcinogens: N-nitrosaminesKamila Blum, Rex FitzGerald, Martin F Wilks, et al.Zeitschrift Fur Kardiologie|September 1, 1985
[Brain abscess in a bidirectional atrial septal defect in adulthood]R Röder, R Erbel, B Henkel, et al.Orphanet Journal of Rare Diseases|May 27, 2020
Saccadic reaction time and ocular findings in phenylketonuriaSusanne Hopf, Caroline Nowak, Julia B Hennermann, et al.Alcohol (Fayetteville, N.Y.)|June 21, 2024
Heart rate variability: A primer for alcohol researchersRaizel M Frasier, Thatiane de Oliveira Sergio, Phillip A Starski, et al.Neurobiology of Aging|April 14, 2026
Altered theta distribution and coherence during set-shifting in older ageMargarita Darna, Anni Richter, Jens-Max Hopf, et al.Journal of Neurology|November 7, 2002
Seventh nerve palsies may be the only clinical sign of small pontine infarctions in diabetic and hypertensive patientsFrank Thömke, Peter P Urban, Jürgen J Marx, et al.European Journal of Radiology|September 22, 2001
Time course of lesion development in patients with acute brain stem infarction and correlation with NIHSS scoreS Fitzek, C Fitzek, P P Urban, et al.Die Rehabilitation|November 12, 2021
[Satisfaction of Rehabilitation Patients on Social Media Websites and Online Rating Portals]Christiane Patzelt, Susann Kiss, Felix Hopf, et al.Journal of the American Society for Mass Spectrometry|February 1, 2021
Batch Effects in MALDI Mass Spectrometry ImagingBenjamin Balluff, Carsten Hopf, Tiffany Porta Siegel, et al.Hepatology (Baltimore, Md.)|September 26, 2000
Randomized, double-blind, placebo-controlled trial of interferon alfa2a with and without amantadine as initial treatment for chronic hepatitis CS Zeuzem, G Teuber, U Naumann, et al.Pageof 157